CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA
CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA
The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.
The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.
Multibagger Pharma Stock Under Rs 50 To Be in Focus Today as Company Acquires 100 Per Cent Stake in Cibachem General Trading L.L.C
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
From Rs 5.83 to Rs 29.69 Per Share in Just 11 Months & 10 Days: Multibagger Pharma Stock Hit Upper Circuit for Second Straight Day
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.
Promoters hold 66 per cent stake: Pharma penny stock jumps 8.5 per cent; Do You Own It?
The company has a market cap of over Rs 300 crore and the stock is up by 12.4 per cent from its 52-week low of Rs 50.42 per share.
The shares of the company have a PE of 12x whereas the industry PE is 30x.
Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 12,59,50,000 from J D Healthcare
The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.
The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.
Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
Multibagger Pharma Stock Under Rs 30: Company Reports a 45 Per Cent Jump in PAT & FIIs Bought 1,29,48,000 Shares
The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share.
Penny Stock Below Rs 5: Board to Raise Capital, Acquire Controlling Stakes in Two Firms via Share Swap and Expand Business Scope
The stock is up by 57 per cent from its 52-week low of Rs 2.11 per share.
The stock is up by 57 per cent from its 52-week low of Rs 2.11 per share.
Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o
From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent.
From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent.
Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)
The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.
The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.
Eugia Pharma receives USFDA Approval for Dasatinib Tablets
The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share.
The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share.
Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion
The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years.
The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years.